Studies that have linked cancer treatment to heart disease may overlook the impact of cancer itself on the heart, researchers warned last night.
A study at the Royal Brompton Hospital, London, UK, has found impaired heart function in treated and untreated cancer patients.
Researchers used a "subtle" measure of left ventricular function called strain, aimed at indicating how well myocardial fibres function.
The study involved some 43 patients with treated cancer, 36 patients with untreated cancer and 20 healthy volunteers.
The findings were reported to the European Association of Cardiovascular Imaging conference in Seville, Spain.
Researcher Dr Rajdeep Khattar said: “All of the cancer patients had a preserved ejection fraction so by this coarse measure their hearts were functioning normally. But the strain measurements showed that they did have myocardial dysfunction.
“What was really new was the finding of reduced strain, and therefore myocardial dysfunction, in the group of patients with cancer who had not yet received treatment.
"This raises the possibility that the tumour itself may have a direct and deleterious effect on the function of the heart.”
He added: "If it transpires that the patients with reduced strain prior to cancer treatment are more prone to heart failure and death then it would be important to implement closer monitoring of patients with cancer than is conducted currently.”
Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality Heart 3 December 2015; doi: 10.1136/heartjnl-2015-307848

Leave a Reply